Note: Ingredients listed on restricted chemical lists
EC/CAS
220-767-7/2893-78-9
Name of the chemical
Troclosene sodium
Concentration
30-60%
EC/CAS
204-673-3/124-04-9
Name of the chemical
adipic acid
Concentration
10-30%
EC/CAS
217-699-5/1934-21-0
Name of the chemical
Trisodium 5-hydroxy-1-(4-sulphophenyl)-4-(4-sulphophenylazo)pyrazole-3-carboxylate and aluminium lake (17); (CI 19140)
Concentration
0.0-0.4% 10-18%
General Information
Version
0
Revision date
2018-10-30
Product name
Klorkleen White
Product Synonyms
None
1.2.1 Relevant identified uses
Klorkleen White Effervescent NaDCC Tablets with added detergent are used for surface disinfection & cleaning
Manufacturer Name
Medentech
Icons in SDS
Company Information
company name
Medentech
e-mail address of the competent person responsible for the Safety Data Sheet
msds@medentech.com
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H315, H318, H335, H410
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Signal word
DANGER
Health hazards
Statement(s) H315 – Causes skin irritation. H318 - Causes serious eye damage. H335 - May cause respiratory irritation.
Environmental hazards
Statement(s) H410 - Very toxic to aquatic life with long lasting effects.
Supplemental label elements
EUH031- Contact with acids liberates toxic gas.
Prevention
P261 - Avoid breathing dust/fumes. P273 - Avoid release to the environment. P280 – Wear protective gloves/ eye protection.
Response
P305 + P351 + P338 - IF IN EYES - Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312 – Immediately call a POISON CENTER or doctor/physician. P391 - Collect spillage.
Precautionary statements
- Storage P403 + P233 - Store in a well-ventilated place. Keep container tightly closed. - Disposal P501 - Dispose of contents and container in accordance with applicable local, regional, national, and/or international regulations.
2.3 Other hazards
Short-Term Exposure (Acute) Inhalation: This material contained in this tablet in solid form is not expected to produce respiratory effects. Particles of respirable size are generally not encountered. The respirable fraction for the tablet active ingredient is typically less than 0.1% by weight for the granular and extra granular grades. If it is ground or otherwise in a powdered form, effects similar to a corrosive substance may occur. May cause severe irritation of the respiratory tract with coughing, choking, pain and possibly burns of the mucous membranes. If significant or prolonged exposure occurs, pulmonary oedema may develop, either immediately or more often within a period of 5-72 hours. The symptoms may include tightness in the chest, dyspnea, frothy sputum, cyanosis, and dizziness. Physical findings may include moist rales, low blood pressure and high pulse pressure. Severe cases may be fatal. Eyes: This material is irritating to the eye. Direct contact may cause severe irritation, pain and burns, possibly severe, and permanent damage including blindness. The degree of injury depends on the concentration and duration of contact. Skin: Direct contact with wet material or moist skin may cause severe irritation, pain, and possibly burns. Dry material is less irritating than wet material. This material is not a skin sensitiser based on studies with guinea pigs. Ingestion: Not a likely route of exposure. Harmful if swallowed. Ingestion may cause immediate pain and severe burns of the mucous membranes. There may be discoloration of the tissues. Swallowing and speech may be difficult at first and then almost impossible. The effects on the oesophagus and gastrointestinal tract may range from irritation to severe corrosion. Oedema of the epiglottis and shock may occur. Repeated Exposure (Chronic) Based on animal studies, exposure to concentrations of monosodium cyanurate at the solubility limit may cause cardiovascular, kidney and urinary bladder effects.
Medical Conditions Generally Aggravated by Exposure
eye disorders, respiratory disorders, skin disorders and allergies. TARGET ORGANS: cardiovascular system, kidneys, bladder.
PBT Substances
The substances contained in this preparation are not identified as PBT substances
2.1 Classification of the substance or mixture
Contact Hazard – Eye: Category 1 – causes serious eye damage. Skin Irrit. –Category 2 – causes skin irritation. Target Organ Toxicity (single exposure): Category 3 – May cause respiratory tract irritation. Hazardous to Aquatic Environment - Acute Hazard: Category 1 - Very toxic to aquatic life. Hazardous to Aquatic Environment - Chronic Hazard: Category 1 - Very toxic to aquatic life with long lasting effects. Additional Information: EUH031 – Contact with acids liberates toxic gases.